These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-002440-96 A randomised placebo controlled trial of itraconazole in the treatment of fungal-sensitised patients with severe asthma and without ABPA. 2006-12-22 due-trials
Ongoing 2004-002799-41 Iontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders not-yet-due
Ongoing 2004-003833-15 A randomised parallel group study to investigate the effect of Seretide withdrawal in COPD using non-invasive biomarkers and physiological measurements not-yet-due
Ongoing 2005-001824-35 Non-randomised phase II trial of Sequential Therapy of Imiquimod followed by Vaccination with TA CIN for High Grade VIN not-yet-due
Ongoing 2005-003775-21 Effects of atorvastatin on microcirculatory endothelial function in patients with systemic sclerosis not-yet-due
Ongoing 2005-003845-15 A cluster randomised control trial to measure the benefit of fluoride varnish in preventing dental decay when applied to the permanent teeth of children for three years in the school setting not-yet-due
Ongoing 2006-000193-77 Protective analgesia using bupivacaine and conventional release ibuprofen versus bupivacaine and sustained release ibuprofen for postoperative pain relief in patients undergoing third molar surgery: a... not-yet-due
Not reported Terminated 2006-000900-17 A randomised double-blind placebo controlled trial of the oral bisphosphonate, Alendronate, plus intravenous pamidronate, in active diabetic Charcot neuroarthropathy (CN). 2010-12-06 due-trials
Ongoing 2006-006032-22 TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis not-yet-due
Ongoing 2006-006619-64 Randomised Controlled Trial of Lapatinib (A Her1/2 Tyrosine Kinase Inhibitor) on Epithelial Proliferation and Apoptosis in Ductal Cancer in Situ. not-yet-due
Not reported 2007-002571-14 The Potential use of Larval Therapy/Biogun and Silver to Reduce Colonisation of MRSA in Diabetic Foot Ulcers. 2009-03-31 due-trials
Ongoing 2008-005466-30 Effect of Perioperative AntiHER2 Therapy on Early Breast Cancer Study - Biological Phase not-yet-due
Reported results 2009-010725-39 A randomised controlled trial to measure the effects and costs of a dental caries prevention regime for young children attending primary care dental services 2015-06-16 due-trials
Ongoing 2011-005151-13 Open-label Pilot Study of Memantine in Chronic Cough Patients Attending a Specialist Clinic not-yet-due
Ongoing 2016-000754-35 The effect of Denosumab on Pain and bone Marrow Lesions in symptomatic Knee Osteo-arthritis: A Randomised Double Blind Placebo controlled Clinical Trial not-yet-due
Ongoing 2016-002651-25 A Phase II Randomised Controlled Study of Oral Prednisolone in Early Diffuse Cutaneous Systemic Sclerosis not-yet-due
Ongoing 2016-003725-42 Does Interleukin-1 Receptor Antagonist Improve Outcome following aneurysmal Subarachnoid Haemorrhage (aSAH)? A Phase III trial not-yet-due
Ongoing 2016-004618-93 Evaluation of the safety of CEdiranib in the prevention of Bowel perforation in platinum-resistant Ovarian Cancer not-yet-due